174 related articles for article (PubMed ID: 29912760)
1. The Role of Insulin-like Growth Factor (IGF) Axis in Early Diagnosis of Pancreatic Adenocarcinoma (PDAC).
Wlodarczyk B; Gasiorowska A; Malecka-Panas E
J Clin Gastroenterol; 2018 Aug; 52(7):569-572. PubMed ID: 29912760
[TBL] [Abstract][Full Text] [Related]
2. Glucagon/insulin ratio as a potential biomarker for pancreatic cancer in patients with new-onset diabetes mellitus.
Kolb A; Rieder S; Born D; Giese NA; Giese T; Rudofsky G; Werner J; Büchler MW; Friess H; Esposito I; Kleeff J
Cancer Biol Ther; 2009 Aug; 8(16):1527-33. PubMed ID: 19571666
[TBL] [Abstract][Full Text] [Related]
3. Adverse Oncologic Impact of New-Onset Diabetes Mellitus on Recurrence in Resected Pancreatic Ductal Adenocarcinoma: A Comparison With Long-standing and Non-Diabetes Mellitus Patients.
Lee S; Hwang HK; Kang CM; Lee WJ
Pancreas; 2018 Aug; 47(7):816-822. PubMed ID: 29975349
[TBL] [Abstract][Full Text] [Related]
4. Diabetes associated with pancreatic ductal adenocarcinoma is just diabetes: Results of a prospective observational study in surgical patients.
Dugnani E; Gandolfi A; Balzano G; Scavini M; Pasquale V; Aleotti F; Liberati D; Di Terlizzi G; Petrella G; Reni M; Doglioni C; Bosi E; Falconi M; Piemonti L
Pancreatology; 2016; 16(5):844-52. PubMed ID: 27546476
[TBL] [Abstract][Full Text] [Related]
5. Type 2 Diabetes Mellitus and Its Association with the Risk of Pancreatic Carcinogenesis: A Review.
Biadgo B; Abebe M
Korean J Gastroenterol; 2016 Apr; 67(4):168-77. PubMed ID: 27112242
[TBL] [Abstract][Full Text] [Related]
6. The adaptor protein CrkII regulates IGF-1-induced biological behaviors of pancreatic ductal adenocarcinoma.
Liu R; Wang Q; Xu G; Li K; Zhou L; Xu B
Tumour Biol; 2016 Jan; 37(1):817-22. PubMed ID: 26250463
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
[TBL] [Abstract][Full Text] [Related]
8. Clinical profiles and long-term outcomes of patients with pancreatic ductal adenocarcinoma and diabetes mellitus.
Ben Q; Xu M; Jiang Y; Yuan Y; Wang K; Fang J; Li Z
Diabetes Metab Res Rev; 2012 Feb; 28(2):169-76. PubMed ID: 22423386
[TBL] [Abstract][Full Text] [Related]
9. Clinical Implications of NRAS Overexpression in Resectable Pancreatic Adenocarcinoma Patients.
Martinez-Useros J; Li W; Georgiev-Hristov T; Fernandez-Aceñero MJ; Borrero-Palacios A; Perez N; Celdran A; Garcia-Foncillas J
Pathol Oncol Res; 2019 Jan; 25(1):269-278. PubMed ID: 29101736
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer.
Polvani S; Tarocchi M; Tempesti S; Bencini L; Galli A
World J Gastroenterol; 2016 Feb; 22(8):2441-59. PubMed ID: 26937133
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor 1 and insulin-like growth factor binding protein 2 serum levels as potential biomarkers in differential diagnosis between chronic pancreatitis and pancreatic adenocarcinoma in reference to pancreatic diabetes.
Włodarczyk B; Borkowska A; Włodarczyk P; Małecka-Panas E; Gąsiorowska A
Prz Gastroenterol; 2021; 16(1):36-42. PubMed ID: 33986886
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-891b is an independent prognostic factor of pancreatic cancer by targeting Cbl-b to suppress the growth of pancreatic cancer cells.
Dong Q; Li C; Che X; Qu J; Fan Y; Li X; Li Y; Wang Q; Liu Y; Yang X; Qu X
Oncotarget; 2016 Dec; 7(50):82338-82353. PubMed ID: 27494897
[TBL] [Abstract][Full Text] [Related]
13. The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers.
Camidge DR; Dziadziuszko R; Hirsch FR
Clin Lung Cancer; 2009 Jul; 10(4):262-72. PubMed ID: 19632946
[TBL] [Abstract][Full Text] [Related]
14. Adipose Triglyceride Lipase (ATGL) Expression Is Associated with Adiposity and Tumor Stromal Proliferation in Patients with Pancreatic Ductal Adenocarcinoma.
Grace SA; Meeks MW; Chen Y; Cornwell M; Ding X; Hou P; Rutgers JK; Crawford SE; Lai JP
Anticancer Res; 2017 Feb; 37(2):699-703. PubMed ID: 28179319
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia.
Hirakawa T; Yashiro M; Doi Y; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Kimura K; Amano R; Hirakawa K
PLoS One; 2016; 11(8):e0159912. PubMed ID: 27487118
[TBL] [Abstract][Full Text] [Related]
16. Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.
Chu CK; Mazo AE; Sarmiento JM; Staley CA; Adsay NV; Umpierrez GE; Kooby DA
J Am Coll Surg; 2010 Apr; 210(4):463-73. PubMed ID: 20347739
[TBL] [Abstract][Full Text] [Related]
17. The Interface of Pancreatic Cancer With Diabetes, Obesity, and Inflammation: Research Gaps and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
Abbruzzese JL; Andersen DK; Borrebaeck CAK; Chari ST; Costello E; Cruz-Monserrate Z; Eibl G; Engleman EG; Fisher WE; Habtezion A; Kim SK; Korc M; Logsdon C; Lyssiotis CA; Pandol SJ; Rustgi A; Wolfe BM; Zheng L; Powers AC
Pancreas; 2018; 47(5):516-525. PubMed ID: 29702529
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus does not impact on clinically relevant pancreatic fistula after partial pancreatic resection for ductal adenocarcinoma.
Malleo G; Mazzarella F; Malpaga A; Marchegiani G; Salvia R; Bassi C; Butturini G
Surgery; 2013 May; 153(5):641-50. PubMed ID: 23276391
[TBL] [Abstract][Full Text] [Related]
19. Insulin/IGF-driven cancer cell-stroma crosstalk as a novel therapeutic target in pancreatic cancer.
Mutgan AC; Besikcioglu HE; Wang S; Friess H; Ceyhan GO; Demir IE
Mol Cancer; 2018 Feb; 17(1):66. PubMed ID: 29475434
[TBL] [Abstract][Full Text] [Related]
20. Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma.
An W; Ben QW; Chen HT; Zheng JM; Huang L; Li GX; Li ZS
Ann Surg Oncol; 2012 Nov; 19(12):3971-8. PubMed ID: 22622471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]